Tome Biosciences is a biotechnology company specializing in programmable genomic integration technology. They focus on developing tools that enable the insertion of genetic sequences into any location within a genome, a capability that has the potential to transform genomic medicine. The company's mission is to re-write patient stories through innovative therapeutic solutions, particularly in the areas of gene therapy and cell therapy. Tome emphasizes a collaborative and inclusive workplace culture that values diverse perspectives and fosters innovation. Employees at Tome are encouraged to challenge the status quo and contribute to advancements in scientific research, all while adhering to high standards of quality and integrity in their work. Through cutting-edge research and development efforts, Tome aims to create impactful treatments that improve patient outcomes.